Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00941980 · ClinicalTrials.gov registry record
Osteocel® Plus in Posterior Lumbar Interbody Fusion (PLIF)
A clinical trial, sponsored by NuVasive.
- Completed
- Registry status
- 28
- Enrollment target
NCT00941980 is a clinical trial that has completed, run by NuVasive. The registered enrollment target is 28 participants.
The verdict
NCT00941980 has completed, sponsored by NuVasive.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
This study is being conducted to determine the percentage of patients with solid spinal fusions after being treated with Osteocel Plus in a PLIF procedure. Due to the unique processing conditions, Osteocel Plus retains a high concentration of stem cells attached to the allograft bone matrix, so it is hypothesized that the fusion rate with Osteocel Plus will be comparable to published data for autograft. The Osteocel product family has already been used in approximately 20,000 cases worldwide.
Interventions
- BIOLOGICAL Osteocel Plus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2009-06 |
| Est. Completion | 2012-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00941980
The ClinicalTrials.gov registry entry for NCT00941980 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NuVasive, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Osteocel Plus is the first listed.
NCT00941980 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00941980 about?
NCT00941980 is a clinical study titled "Osteocel® Plus in Posterior Lumbar Interbody Fusion (PLIF)". This study is being conducted to determine the percentage of patients with solid spinal fusions after being treated with Osteocel Plus in a PLIF procedure. Due to the unique processing conditions, Osteocel Plus retains a high concentration of stem cells attached to the allograft bone matrix, so it i...
What is the current status of trial NCT00941980?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2009-06. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00941980?
The interventions under investigation include: Osteocel Plus (BIOLOGICAL).
Who is sponsoring clinical trial NCT00941980?
This trial is sponsored by NuVasive, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.